Wang Jun, Zhuang Shougang
Department of Nephrology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China; and.
Department of Nephrology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China; and
Am J Physiol Renal Physiol. 2017 Sep 1;313(3):F721-F728. doi: 10.1152/ajprenal.00141.2017. Epub 2017 Jun 14.
Src family kinases (SFKs) belong to nonreceptor protein tyrosine kinases and have been implicated in the regulation of numerous cellular processes, including cell proliferation, differentiation, migration and invasion, and angiogenesis. The role and mechanisms of SFKs in tumorgenesis have been extensively investigated, and some SFK inhibitors are currently under clinical trials for tumor treatment. Recent studies have also demonstrated the importance of SFKs in regulating the development of various fibrosis-related chronic diseases (e.g., idiopathic pulmonary fibrosis, liver fibrosis, renal fibrosis, and systemic sclerosis). In this article, we summarize the roles of SFKs in various chronic kidney diseases, including glomerulonephritis, diabetic nephropathy, human immunodeficiency virus-associated nephropathy, autosomal dominant form of polycystic kidney disease, and obesity-associated kidney disease, and discuss the mechanisms involved.
Src家族激酶(SFKs)属于非受体蛋白酪氨酸激酶,参与众多细胞过程的调控,包括细胞增殖、分化、迁移、侵袭及血管生成。SFKs在肿瘤发生中的作用和机制已得到广泛研究,目前一些SFK抑制剂正处于肿瘤治疗的临床试验阶段。最近的研究还表明,SFKs在调节各种纤维化相关慢性疾病(如特发性肺纤维化、肝纤维化、肾纤维化和系统性硬化症)的发展中具有重要作用。在本文中,我们总结了SFKs在各种慢性肾脏病中的作用,包括肾小球肾炎、糖尿病肾病、人类免疫缺陷病毒相关性肾病、常染色体显性多囊肾病和肥胖相关性肾病,并讨论了其中涉及的机制。